that were extracted and analysed blindly alongside the familial samples. SNPs with r 2 <0.8 were removed to generate a final set of 10,652,600 SNPs. Quality 2 1 1 control was undertaken for the imputed data on the 999 individuals with lipidomics 2 1 2 available, as follows: SNPs that were identified as Mendelian inconsistencies (--2 1 3 mendel-multigen) were marked as missing. SNPs with low call rates (--geno 0.05), 2 1 4 low minor allele frequency (--maf 0.05), and those that failed checks of Hardy-2 1 5
Weinberg Equilibrium (--hwe 1e-8) were excluded, resulting in a final count of 2 1 6 5,280,459 SNPs available for genome-wide association analyses. Family-based genome-wide association studies 2 1 9
Linear mixed modelling approaches were used to account for family structure. Family-based genome-wide association analyses were undertaken for each lipid trait analyses (--mlma). Genomic control inflation factors from the GWAS analyses can be 2 2 3
found in Table S2 . The least significant P-values of the significantly associated SNPs outcomes are presented in Table S3 . As many GWAS associated SNPs were in activity, Figure 1B ). Structure-based summations of total abundance and ratios that 2 6 3 have previously been associated in the literature with cardiovascular risk 12 were also 2 6 4 assessed for genetic associations. A list of the species and measurements studied, and 2 6 5 summary statistics are presented in Table S4 . Heritability results are depicted in Figure 2 (a detailed list is provided in Table S5 ). Genome-wide association study of N-acyl ethanolamines 2 7 8
There were conventionally GWAS significant (P<5x10 -8 ) associations between four Table S6 ), which catalyses the degradation of NAEs 2 8 3
( Figure 1A ). The leading SNP is a missense variant (rs324420; C385A; P129T) and AA genotype of the lead SNP rs324420 had 22% increased mean plasma 2 8 9 concentration of PEA (2.19 ± 1.57 ng/ml, n=51) compared to those carrying the CC 2 9 0 genotype (1.79 ± 1.29 ng/ml, n=639). A LocusZoom plot of the association with the 2 9 1 lipid PEA is depicted in Figure 4 , with the 22-chromosome Manhattan plot depicted 2 9 2 in Figure S3 . Genome-wide association study of ceramides and related sphingolipids 2 9 5
Seven CER[NS] and two CER[NDS] species were significantly associated with SNPs depicted in Figure S4 , and further details in Table S7 ). Assessing the SNPs using 1 3
GTEx confirmed them as liver eQTLs (Table S8) found 20,000 bases downstream of 2 9 9 the gene encoding the third subunit of serine palmitoyltransferase (SPTLC3; Figure   3 0 0 6), which catalyses the rate-limiting step 10 of CER biosynthesis ( Figure 1B ). The 3 0 1
SNPs are associated with differences in the expression of the SPTLC3 gene in the 3 0 2 liver, leading to changes in CER production that are reflected in altered plasma levels. with 19-and 20-carbon sphingosine bases, were found associated with the same SNPs 3 0 9
at the SPTLC3 locus (Table S8 ). A novel association was identified for in Table S7 ). Association of ceramides and related traits with hematological phenotypes 3 1 5
The Gene Atlas Browser of PheWAS in the UK Biobank study was used to assess the further details in Table S7 ). All significant SNPs were confirmed eQTLs of DEGS1 in whole blood (Table S8 ). This locus associated with numerous blood cell phenotypes CER[N(24)S(16)] (e.g. rs7160525, P=5.67x10 -10 ; Figure S7 ). This enzyme is involved
in the recycling of CER[NS] species from sphingosine-1-phosphate and ceramide-1-
phosphate (C1P) ( Figure 1B ). All signficiant SNPs at this locus were also associated 3 3 0
with blood cell phenotypes, identified in the UK Biobank data (e.g. rs7160525 and 3 3 1 mean platelet (thrombocyte) volume, P=3.28x10 -29 ; Table S8 ). The significant SNPs between the SPTLC3 locus and the cardiovascular disease endpoints (Table S9) . We show, for the first time, the substantial variation in heritability estimated for an associations between lipids and variants of the enzymes in their respective metabolic 3 5 0 pathways. We have provided the first GWAS significant evidence of association 3 5 1
between SNPs in the FAAH gene and plasma NAEs. Additionally, we have extended 3 5 2 the previously described association between SNPs in the SPTLC3 gene and plasma 3 5 3
CERs to a wider range of species. Our results indicate that these two genes are the 3 5 4
major loci influencing plasma levels of NAEs and CERs, respectively. In addition, we We show for the first time associations at GWAS significance for NAE species with the SNP (DHEA, LEA, and VEA), though we did not find significant association at the locus for AEA, STEA or OEA species. We observed a similar trend to the participants with the missense AA genotype, and those with the wildtype CC 3 7 0 genotype ( Figure S8 ). formation through platelet activating factor 48 . However, further studies will be 4 2 6 required to identify the mechanism of the association between genetically determined 4 2 7 plasma ceramide levels and blood cell phenotypes. between CD83 and CER is currently unknown, but given the involvement of ceramide Association between some CER species and the SPTLC3 SNP rs680379 has been 4 3 8
identified previously through the use of shotgun lipidomics for five CER species for the de novo biosynthesis of CER, this association may have wider implications. Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I., Willer, C.J., et al. (2010) . Ganna, A., Chen, J., Buchkovich, M.L., Mora, S., et al. (2013) . Discovery and 4 8 5 refinement of loci associated with lipid levels. Nat. Genet. 45, 1274 Genet. 45, -1285 30. Smith, G.D., and Hemani, G. (2014) . Mendelian randomization: Genetic anchors 5 7 9
for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89-R98. Evidence for a link between defects in the endocannabinoid system and problem drug obesity. PLoS One 5, 1-6. This figure depicts the heritability estimated for each lipid species using SNP-based GCTA software (y-axis) and reported pedigree-based QTDT software (x-axis). This data is presented in detail in Table S5 . The radar plot depicts the P-value for association between the lead SNP and eQTL of FAAH (rs324420) and each NAE species. The P-values were grouped into "<5x10 -8 " (P<5x10 -8 , outermost ring), "x10 -6 " (P=5.0x10 -8 -9.9x10 -6 [of which there are no NAE species]), "x10 -5 " (1.0x10 -5 -9.9x10 -5 ), and "NS" (not significant) at the center of the radar.
Figure 4: LocusZoom plot of the association of PEA with FAAH SNP rs324420
The LocusZoom plot depicts the association of N-acyl ethanolamine lipid species PEA with FAAH SNP rs324420 on chromosome 1. The r 2 for each SNP is depicted in colour. The plot was created using the LocusZoom plot tools at http://locuszoom.sph.umich.edu/.
Figure 5: Family-based GWAS results for CER[NS] and precursor CER[NDS] with an exemplar SNP in serine palmitoyltransferase (SPTLC3).
The radar plot depicts the P-value for association between the lead SNP and liver eQTL of SPTLC3 (rs680379) with CER species. The P-values were grouped into "<5x10 -8 " (P<5x10 -8 , outermost ring), "x10 -6 " (P=5.0x10 -8 -9.9x10 -6 , "x10 -5 " (1.0x10 -5 -9.9x10 -5 ), and "NS" (not significant) at the center of the radar.
Figure 6: LocusZoom plot of the association of CER[N(24)S(19)] with SPTLC3 SNP rs680379
The LocusZoom plot depicts the association of CER[N(24)S(19)] with FAAH SNP rs680379 on chromosome 1. While there is a group of lead SNPs, this SNP was depicted as it has been identified previously to associate at GWAS with sphingolipid species. The r 2 for each SNP is depicted in colour. The plot was created using the LocusZoom plot tools at http://locuszoom.sph.umich.edu/. 
